Bile Acids in Nonalcoholic Fatty Liver Disease: New Concepts and Therapeutic Advances

被引：23

作者：

Cruz-Ramon, Vania ^{[1
]}

Chinchilla-Lopez, Paulina ^{[1
]}

Ramirez-Perez, Oscar ^{[1
]}

Mendez-Sanchez, Nahum ^{[1
]}

机构：

[1] Med Sur Clin & Fdn, Liver Res Unit, Puente Piedra 150, Mexico City 14050, DF, Mexico

来源：

ANNALS OF HEPATOLOGY | 2017年 / 16卷

关键词：

Bile acids; NAFLD; Metabolism; Metabolic syndrome; NUCLEAR RECEPTOR; STEATOHEPATITIS; IDENTIFICATION; EPIDEMIOLOGY; METABOLISM; ALPHA;

D O I：

10.5604/01.3001.0010.5498

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Nonalcoholic liver disease (NAFLD) is a major emerging health burden that is a common cause of illness and death worldwide. NAFLD can progress into nonalcoholic steatohepatitis (NASH) which is a severe form of liver disease characterized by inflammation and fibrosis. Further progression leads to cirrhosis, which predisposes patients to hepatocellular carcinoma or liver failure. The mechanism of the progression from simple steatosis to NASH is unclear. However, there are theories and hypothesis which support the link between disruption of the bile acids homeostasis and the progression of this disorder. Previous studies have been demonstrated that alterations of these pathways can lead to dysregulation of energy balance and an increase of liver inflammation and fibrosis. In this review, we summarized the current knowledge of the interaction between BA and the process related to the development of NAFLD, besides, the potential targets for novel therapies.

引用

页码：S58 / S67

页数：10

共 50 条

[41] Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship [J].

Arrese, Marco ;

Cortes, Victor ;

Barrera, Francisco ;

Nervi, Flavio .

CURRENT OPINION IN GASTROENTEROLOGY, 2018, 34 (02) :90-96

[42] Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease [J].

Gentile, Christopher L. ;

Frye, Melinda A. ;

Pagliassotti, Michael J. .

BIOFACTORS, 2011, 37 (01) :8-16

[43] Advances in Optical Imaging of Nonalcoholic Fatty Liver Disease [J].

Shen, Yang ;

Zhou, Qianhui ;

Li, Wei ;

Yuan, Lin .

CHEMISTRY-AN ASIAN JOURNAL, 2022, 17 (12)

[44] Advances in ultrasound elastography for nonalcoholic fatty liver disease [J].

Yoneda, Masato ;

Honda, Yasushi ;

Nogami, Asako ;

Imajo, Kento ;

Nakajima, Atsushi .

JOURNAL OF MEDICAL ULTRASONICS, 2020, 47 (04) :521-533

[45] Advances in ultrasound elastography for nonalcoholic fatty liver disease [J].

Masato Yoneda ;

Yasushi Honda ;

Asako Nogami ;

Kento Imajo ;

Atsushi Nakajima .

Journal of Medical Ultrasonics, 2020, 47 :521-533

[46] New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis [J].

Pydyn, Natalia ;

Miekus, Katarzyna ;

Jura, Jolanta ;

Kotlinowski, Jerzy .

PHARMACOLOGICAL REPORTS, 2020, 72 (01) :1-12

[47] Therapeutic Potential of Natural Plants Against Non-Alcoholic Fatty Liver Disease: Targeting the Interplay Between Gut Microbiota and Bile Acids [J].

Sun, QinMei ;

Xin, Xin ;

An, ZiMing ;

Hu, YiYang ;

Feng, Qin .

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12

[48] New Insights into the Role of Iron in the Development of Nonalcoholic Fatty Liver Disease [J].

Sharp, Paul A. .

HEPATOLOGY, 2010, 52 (02) :408-410

[49] New insights into the pathophysiology of nonalcoholic fatty liver disease [J].

Chavez-Tapia, Norberto C. ;

Uribe, Misael ;

Ponciano-Rodriguez, Guadalupe ;

Medina-Santillan, Roberto ;

Mendez-Sanchez, Nahum .

ANNALS OF HEPATOLOGY, 2009, 8 :S9-S17

[50] Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease? [J].

Auguet, Teresa ;

Bertran, Laia ;

Barrientos-Riosalido, Andrea ;

Fabregat, Blanca ;

Villar, Beatriz ;

Aguilar, Carmen ;

Sabench, Fatima .

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (20)

← 1 2 3 4 5 →